MASHINIi

Disc Medicine, Inc..

IRON.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for patients suffering from serious hematologic diseases. The company's pipeline includes programs targeting hepcidin biology, including bitopertin, a Pha...Show More

Ethical Profile

Mixed.

Disc Medicine, Inc. is fundamentally committed to improving health, focusing on developing novel treatments for serious hematologic diseases like erythropoietic porphyrias and anemia of myelofibrosis, directly addressing unmet medical needs. However, as a biopharmaceutical company, it likely relies on animal testing for drug development, a common industry practice, though specific policies for reducing this are not publicly detailed. For other ethical areas such as fair pay, ethical sourcing, and environmental impact, reports suggest insufficient public information to provide a comprehensive assessment.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-30
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Disc Medicine, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Disc Medicine, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases.

1
The company does not offer lending, insurance, or deposit services to consumers, nor does it engage in financial activities.
2
Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, financial literacy initiatives, debt burden ratio, geographic inclusion for banking, and product simplicity for financial products, are not applicable to its core business model.
3

Fair Pay & Worker Respect

0

No evidence available to assess Disc Medicine, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Disc Medicine, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess Disc Medicine, Inc. on Honest & Fair Business.

Kind to Animals

0

Disc Medicine conducts preclinical studies using various animal models for its drug candidates, such as MWTX-003.

1
However, the provided articles do not contain specific, concrete data points regarding the company's animal testing policy, the volume of animals used, or any investments in animal-free technologies. There is also no information on the company's use of alternative testing methods, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits, or cage-free sourcing. While Disc Medicine announced a collaboration with NIH to study bitopertin,
2
there is no evidence of participation in multi-stakeholder initiatives to develop industry-wide animal-free testing standards. Similarly, while the company received Orphan Drug Designation from the FDA and a positive opinion from the European Committee for Orphan Medical Products,
3
there is no evidence of active engagement in animal welfare policy improvement or advocacy for higher standards.

No War, No Weapons

0

The provided articles for Disc Medicine, Inc. (IRON.US) do not contain any specific data points or information relevant to assessing the company against the 'No War, No Weapons' ethical value or its associated Key Performance Indicators. The company is described as a clinical-stage biopharmaceutical company focused on hematologic diseases, with no mention of any activities related to arms, defense, or military contracts.

1

Planet-Friendly Business

-30

The company has no reported environmental compliance violations, fines, or regulatory actions.

1
No information is available regarding its performance on other planet-friendly business metrics, including carbon emissions, renewable energy use, water consumption, waste diversion, or climate targets.
2

Respect for Cultures & Communities

0

The provided articles do not contain any specific data points or information related to Disc Medicine, Inc.'s performance concerning Respect for Cultures & Communities.

1
There is no evidence regarding formal partnerships, community reinvestment, cultural incidents, impact assessments, local employment, grievance mechanisms, or any other relevant metrics for this value.
2

Safe & Smart Tech

0

No specific, concrete evidence related to IRON.US and the 'Safe & Smart Tech' value or any of its associated KPIs was found in the provided articles. The articles either failed to load, were general industry news, or explicitly stated they contained no data relevant to IRON.US.

1

Zero Waste & Sustainable Products

0

No evidence available to assess Disc Medicine, Inc. on Zero Waste & Sustainable Products.

Own Disc Medicine, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.